Drug development runs on a brutal arithmetic. Most candidates fail, and they usually fail late, after the money is spent. A proposal published this week argues that the way out is to stop treating biology as something you can only poke at in a dish and start treating it as something you can simulate.
Le Song, Eran Segal, and Eric Xing laid out the engineering blueprint in a Nature Medicine Perspective, How to build an AI-driven digital organism.
